Cary Research Group, LLC

Cary, North Carolina 27518

0 studies enrolling now · 4 studies all time

What they study most

ASCVD, Atherosclerotic Cardiovascular Disease, Dyslipidemia, Dyslipidemias, Familial Hypercholesterolemia, High Cholesterol, Hypercholesterolemia, Paroxysmal Supraventricular Tachycardia, Type2 Diabetes

Studies at this site

• Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling